To the Editor.—
Miao et al1 reported that protoporphyrin levels in erythrocytes of patients with erythropoietic protoporphyria (EPP) were higher in winter than in summer and were elevated during administration of oral beta carotene. In developing a possible explanation for the protective effect of the carotenoid, they cited Piomelli et al2 in support of statements that protoporphyrin leaks from erythrocytes of patients with EPP, and protoporphyrin is rapidly cleared from the plasma in vivo. Since this is not the first time Piomelli et al were cited about in vivo events in EPP,3 a correction is in order. Despite use of the term "in vivo" in the title of the report, the study was an in vitro one. In fact, Scholnick et al4 published information concerning in vivo turnover of plasma protoporphyrin. They administered tritiated δ-aminolevulinic acid (ALA-3H) and glycine labeled with radioactive carbon (glycine
Johnson JA, Fusaro RM. Effect of Oral Carotenoid Therapy on Erythrocyte Protoporphyrin Levels. Arch Dermatol. 1980;116(8):863–864. doi:10.1001/archderm.1980.01640320013007
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: